COEGIN fundamentals
Key facts
Market capitalization103.64 MSEK
Basic EPS (TTM)−1.40SEK
Founded2016
CEOJens Eriksson
Websitecoeginpharma.com
About
Coegin Pharma AB is a biotechnology company with projects in hair growth, skin pigmentation, myocardial infarction, leukemia. What the projects have in common is that they are based on validated technology platforms and collaborations with researchers and academics internationally. Coegin Pharma was founded in 2005 and is headquartered in Lund, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
−8.00 M
−6.00 M
−4.00 M
−2.00 M
0.00
Revenue
Net income
Net margin %
Estimates
Revenue and Earnings forecasts and estimates accuracy
Dividends
Dividend yield, history and sustainability
COEGIN does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company